EAM Investors’s Protagonist Therapeutics PTGX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.94M	Sell	27,914 -50,584	-64%	-$4.48M	0.34%	140
2025 Q4	$6.86M	Sell	78,498 -1,569	-2%	-$128K	0.76%	15
2025 Q3	$5.23M	Buy	80,067 +8,096	+11%	+$460K	0.6%	52
2025 Q2	$3.98M	Buy	71,971 +2,790	+4%	+$134K	0.6%	79
2025 Q1	$3.35M	Buy	+69,181	New	+$2.9M	0.58%	77
2023 Q3	–	Sell	-87,953	Closed	-$2.43M	–	361
2023 Q2	$2.43M	Buy	+87,953	New	+$2.2M	0.45%	80
2021 Q3	–	Sell	-101,019	Closed	-$4.53M	–	368
2021 Q2	$4.53M	Buy	+101,019	New	+$3.33M	0.7%	10
2021 Q1	–	Sell	-44,067	Closed	-$888K	–	422
2020 Q4	$888K	Sell	44,067 -30,279	-41%	-$652K	0.15%	277
2020 Q3	$1.45M	Buy	+74,346	New	+$1.4M	0.34%	118